Anti-inflammatory Therapeutics Market Report

Global Anti-inflammatory Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jul 29, 2020
  • PAGES：217
  • REPORT CODE：GMM589897
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Anti-inflammatory therapeutics are drugs used to treat inflammation that occurs after tissues are injured. There are two types of anti-inflammatory therapeutics: one is steroidal anti-inflammatory therapeutics, and the other is non-steroidal anti-inflammatory therapeutics, which are antipyretic and analgesic anti-inflammatory therapeutics referred to in medical practice, such as aspirin.

    There are many inflammations that have not yet found a suitable diagnosis and treatment method. The intake of anti-inflammatory therapeutics can greatly reduce the pain caused by inflammation, and the cost is less than that of surgery. However, taking anti-inflammatory therapeutics will bring certain side effects, which hinders the development of the market to a certain extent.

    The increasing incidence of chronic inflammation and autoimmune diseases has increased the demand for anti-inflammatory therapeutics. In addition, it is expected that the increasing awareness of anti-inflammatory therapeutics and the active measures of governments in the Asia-Pacific region will drive market growth. The research and development of new anti-inflammatory therapeutics by major developers in the market provides opportunities for the development of the anti-inflammatory therapeutics market.

    The Anti-inflammatory Therapeutics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period. The research provides insights for the global Anti-inflammatory Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Anti-inflammatory Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Anti-inflammatory Therapeutics Market Segmentations:

    By Players:

    • Amgen Inc

    • GlaxoSmithKline plc

    • AstraZeneca PLC

    • Novartis AG

    • Eli Lily and Company

    • Johnson & Johnson

    By Types:

    • Nonsteroidal Anti-inflammatory Diseases (NSAIDs)

    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)

    • Corticosteroids

    • Biologics

    • Other

    By End-User:

    • Arthritis

    • Psoriasis

    • Respiratory Disease

    • Multiple Sclerosis

    • Inflammatory Bowel Disease

    • Other Inflammatory Disease

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-inflammatory Therapeutics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs) from 2014 to 2026

      • 1.3.2 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs) from 2014 to 2026

      • 1.3.3 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids from 2014 to 2026

      • 1.3.4 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics from 2014 to 2026

      • 1.3.5 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Arthritis from 2014 to 2026

      • 1.4.2 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Psoriasis from 2014 to 2026

      • 1.4.3 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Respiratory Disease from 2014 to 2026

      • 1.4.4 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Multiple Sclerosis from 2014 to 2026

      • 1.4.5 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease from 2014 to 2026

      • 1.4.6 Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Other Inflammatory Disease from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Anti-inflammatory Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Anti-inflammatory Therapeutics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Anti-inflammatory Therapeutics by Major Types

      • 3.4.1 Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs)

      • 3.4.2 Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs)

      • 3.4.3 Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids

      • 3.4.4 Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics

      • 3.4.5 Anti-inflammatory Therapeutics Market Size and Growth Rate of Other

    4 Segmentation of Anti-inflammatory Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Anti-inflammatory Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Arthritis

      • 4.4.2 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Psoriasis

      • 4.4.3 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Respiratory Disease

      • 4.4.4 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Multiple Sclerosis

      • 4.4.5 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Inflammatory Bowel Disease

      • 4.4.6 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Other Inflammatory Disease

    5 Market Analysis by Major Regions

    • 5.1 Global Anti-inflammatory Therapeutics Production Analysis by Major Regions

    • 5.2 Global Anti-inflammatory Therapeutics Consumption Analysis by Major Regions

    • 5.3 Global Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Commodity of Anti-inflammatory Therapeutics Market in Major Countries

    • 6.1 Top 5 Export Countries in Anti-inflammatory Therapeutics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Anti-inflammatory Therapeutics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Anti-inflammatory Therapeutics Landscape Analysis

    • 7.1 North America Anti-inflammatory Therapeutics Landscape Analysis by Major Types

    • 7.2 North America Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users

    • 7.3 North America Anti-inflammatory Therapeutics Landscape Analysis by Major Countries

      • 7.3.1 United States Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 7.3.2 Canada Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 7.3.3 Mexico Anti-inflammatory Therapeutics Market Volume and Growth Rate

    8 Europe Anti-inflammatory Therapeutics Landscape Analysis

    • 8.1 Europe Anti-inflammatory Therapeutics Landscape Analysis by Major Types

    • 8.2 Europe Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users

    • 8.3 Europe Anti-inflammatory Therapeutics Landscape Analysis by Major Countries

      • 8.3.1 Germany Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.2 UK Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.3 France Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.4 Italy Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.6 Spain Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.7 Belgium Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.8 Poland Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.9 Russia Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 8.3.10 Turkey Anti-inflammatory Therapeutics Market Volume and Growth Rate

    9 Asia Pacific Anti-inflammatory Therapeutics Landscape Analysis

    • 9.1 Asia Pacific Anti-inflammatory Therapeutics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Anti-inflammatory Therapeutics Landscape Analysis by Major Countries

      • 9.3.1 China Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 9.3.2 Japan Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 9.3.4 India Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 9.3.6 South Korea Anti-inflammatory Therapeutics Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Anti-inflammatory Therapeutics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Anti-inflammatory Therapeutics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Anti-inflammatory Therapeutics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 10.3.2 Brazil Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 10.3.3 Nigeria Anti-inflammatory Therapeutics Market Volume and Growth Rate

      • 10.3.4 South Africa Anti-inflammatory Therapeutics Market Volume and Growth Rate 

      • 10.3.5 Argentina Anti-inflammatory Therapeutics Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Amgen Inc

      • 11.1.1 Amgen Inc Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 GlaxoSmithKline plc

      • 11.2.1 GlaxoSmithKline plc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 AstraZeneca PLC

      • 11.3.1 AstraZeneca PLC Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Novartis AG

      • 11.4.1 Novartis AG Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Eli Lily and Company

      • 11.5.1 Eli Lily and Company Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Johnson & Johnson

      • 11.6.1 Johnson & Johnson Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 105 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs) from 2014 to 2026

    • Figure Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs) from 2014 to 2026

    • Figure Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids from 2014 to 2026

    • Figure Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics from 2014 to 2026

    • Figure Anti-inflammatory Therapeutics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Arthritis from 2014 to 2026

    • Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Psoriasis from 2014 to 2026

    • Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Respiratory Disease from 2014 to 2026

    • Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Multiple Sclerosis from 2014 to 2026

    • Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease from 2014 to 2026

    • Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Other Inflammatory Disease from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Anti-inflammatory Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Anti-inflammatory Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Anti-inflammatory Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Anti-inflammatory Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs)

    • Figure Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs)

    • Figure Market Size and Growth Rate of Corticosteroids

    • Figure Market Size and Growth Rate of Biologics

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Anti-inflammatory Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Anti-inflammatory Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Arthritis

    • Figure Market Size and Growth Rate of Psoriasis

    • Figure Market Size and Growth Rate of Respiratory Disease

    • Figure Market Size and Growth Rate of Multiple Sclerosis

    • Figure Market Size and Growth Rate of Inflammatory Bowel Disease

    • Figure Market Size and Growth Rate of Other Inflammatory Disease

    • Table Global Anti-inflammatory Therapeutics Production by Major Regions

    • Table Global Anti-inflammatory Therapeutics Production Share by Major Regions

    • Figure Global Anti-inflammatory Therapeutics Production Share by Major Regions in 2014

    • Figure Global Anti-inflammatory Therapeutics Production Share by Major Regions in 2018

    • Figure Global Anti-inflammatory Therapeutics Production Share by Major Regions in 2026

    • Table Global Anti-inflammatory Therapeutics Consumption by Major Regions

    • Table Global Anti-inflammatory Therapeutics Consumption Share by Major Regions

    • Figure Global Anti-inflammatory Therapeutics Consumption Share by Major Regions in 2014

    • Figure Global Anti-inflammatory Therapeutics Consumption Share by Major Regions in 2018

    • Figure Global Anti-inflammatory Therapeutics Consumption Share by Major Regions in 2026

    • Table North America Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis

    • Table Europe Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Anti-inflammatory Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Anti-inflammatory Therapeutics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Anti-inflammatory Therapeutics Consumption by Types from 2014 to 2026

    • Table North America Anti-inflammatory Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by Types in 2014

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by Types in 2018

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by Types in 2026

    • Table North America Anti-inflammatory Therapeutics Consumption by End-Users from 2014 to 2026

    • Table North America Anti-inflammatory Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by End-Users in 2014

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by End-Users in 2018

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by End-Users in 2026

    • Table North America Anti-inflammatory Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table North America Anti-inflammatory Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2014

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2018

    • Figure North America Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2026

    • Figure United States Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Anti-inflammatory Therapeutics Consumption by Types from 2014 to 2026

    • Table Europe Anti-inflammatory Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by Types in 2014

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by Types in 2018

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by Types in 2026

    • Table Europe Anti-inflammatory Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Europe Anti-inflammatory Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by End-Users in 2014

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by End-Users in 2018

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by End-Users in 2026

    • Table Europe Anti-inflammatory Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Europe Anti-inflammatory Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2014

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2018

    • Figure Europe Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2026

    • Figure Germany Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Anti-inflammatory Therapeutics Consumption by Types from 2014 to 2026

    • Table Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Types in 2014

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Types in 2018

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Types in 2026

    • Table Asia Pacific Anti-inflammatory Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Anti-inflammatory Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by End-Users in 2014

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by End-Users in 2026

    • Table Asia Pacific Anti-inflammatory Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2026

    • Figure China Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandAnti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Anti-inflammatory Therapeutics Consumption Share by Major Countries in 2026

    • Figure GCC Countries Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Anti-inflammatory Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of AstraZeneca PLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC

    • Figure Sales and Growth Rate Analysis of AstraZeneca PLC

    • Figure Revenue and Market Share Analysis of AstraZeneca PLC

    • Table Product and Service Introduction of AstraZeneca PLC

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Eli Lily and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lily and Company

    • Figure Sales and Growth Rate Analysis of Eli Lily and Company

    • Figure Revenue and Market Share Analysis of Eli Lily and Company

    • Table Product and Service Introduction of Eli Lily and Company

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US